百克生物：关于自愿披露吸附无细胞百（二组分）白破联合疫苗（成人及青少年用）临床试验申请获得批准的公告

Core Viewpoint - The company, Baike Bio, has received approval from the National Medical Products Administration for its clinical trial of the Adsorbed Acellular Bivalent Pertussis Vaccine for adults and adolescents [2] Group 1 - The approval notification for the clinical trial was issued on November 12 [2] - The vaccine is intended for use in both adults and adolescents [2]